novo nordisk glp-1 receptor agonist medications introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients Novo asks FDA to prevent
Description
Until more research is available, the use of these drugs in T1D should be done carefully, with a thorough discussion with patients about potential risks and benefits of this approach

Thromb Res

Its recommended to increase the dose gradually (every four weeks) if additional blood sugar management is needed

Md 75, 15231538
Most patients regain weight after stopping their injections, which suggests the need to stay on the medication potentially for a lifetime. Risks and Side Effects of Bariatric Surgery vs

Qin W, Yang J, Ni Y, Deng C, Ruan Q, Ruan J, et al